Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.94 USD | +2.12% | +2.05% | -2.31% |
Feb. 28 | Transcript : Sabra Health Care REIT, Inc., Q4 2023 Earnings Call, Feb 28, 2024 | |
Feb. 28 | Sabra Health Care REIT Q4 Adjusted FFO, Revenue Decline; Issues 2024 Guidance | MT |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- This company will be of major interest to investors in search of a high dividend stock.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- One of the major weak points of the company is its financial situation.
- With a 2024 P/E ratio at 24.04 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.31% | 3.23B | C+ | ||
+4.62% | 55.76B | A- | ||
-11.72% | 17.72B | A- | ||
-5.05% | 13.23B | A | ||
+1.40% | 7.68B | B | ||
-17.93% | 5.39B | B- | ||
+8.62% | 3.28B | C- | ||
-5.42% | 3.06B | B+ | ||
+12.61% | 2.73B | C- | ||
-13.17% | 2.43B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SBRA Stock
- Ratings Sabra Health Care REIT, Inc.